title: [Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells].
abstract: Chemotherapy as a routine method for clinical treatment of cancer has disadvantages such as significant toxicity and strong resistance. In order to improve the efficacy of the drugs and reduce the by-effects, we tried to combine static magnetic field (SMF) with cisplatin or adriamycin. The growth of Hepa1-6 cells treated with the static magnetic field (SMF) combined with cisplatin or adriamycin was significantly inhibited, as detected with MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) test. Combined treatment group cells underwent significant morphological changes as observed by HE (Hematoxylin and eosin) staining under optical microscope. Cell cycle analysis indicated that SMF increased the ratio of cells arrested in G2/M phase caused by cisplatin, and when treated with SMF combined with adriamycin, cells were almost arrested in G1 and G2/M phase. SCGE test showed that SMF can enhance the ability of cisplatin or adriamycin to promote cell DNA damage. Atomic force microscope observation found that the combination of antitumor drugs and magnetic field treatment induced larger and deeper holes on the cell membrane, and surface structure damage is serious. The combination of antitumor drugs and magnetic field technology effectively inhibits the growth of tumor cells, and reduces drug doses. The results implicate this method as potential cancer therapy.
authors.forename: Lingling
authors.initials: L
authors.lastname: Xu
authors.forename: Wei
authors.initials: W
authors.lastname: Guo
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Xueqing
authors.initials: X
authors.lastname: Zhang
authors.forename: Juntao
authors.initials: J
authors.lastname: Yu
authors.forename: Wencai
authors.initials: W
authors.lastname: Wu
authors.forename: Tiejun
authors.initials: T
authors.lastname: Zhao
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle; D045744:Cell Line, Tumor / Q000187:drug effects; D002945:Cisplatin / Q000494:pharmacology*; D004249:DNA Damage; D004317:Doxorubicin / Q000494:pharmacology*; D006801:Humans; D060526:Magnetic Fields
chemical_list: D000970:Antineoplastic Agents; D004317:Doxorubicin; D002945:Cisplatin